Adrian G. Howd is Director & Principal at Brandon Point Industries Ltd.
He is also on the board of Viamet Pharmaceuticals, Inc., Viamet Pharmaceuticals Corp. and Blueberry Therapeutics Ltd.
In his past career he held the position of Chief Executive Officer of Malin Corp. Plc, Executive Vice President for Evotec SE, Research Analyst at ABN AMRO Bank NV (London Branch) (Broker) (Old) and Research Analyst at Joh. Berenberg, Gossler & Co. KG (United Kingdom).
Adrian G. Howd received a doctorate from the University of London.